[1] GARNER H, DE VISSER K E. Immune crosstalk in cancer progression and metastatic spread: a complex conversation [J]. Nature Reviews Immunology, 2020, 20(8): 483-97. [2] SHIRAVAND Y, KHODADADI F, KASHANI S M, et al....
[8] NEGRAO M V,LAM V K,REUBEN A,et al. PD-L1 Expression,tumor mutational burden,and cancer gene mutations are stronger predictors of benefit from immune checkpoint blockade than HLA class Ⅰ genotype in non-small cell lun...
PMID: 34245634.[8] NEGRAO M V,LAM V K,REUBEN A,et al. PD-L1 Expression,tumor mutational burden,and cancer gene mutations are stronger predictors of benefit from immune checkpoint blockade than HLA class Ⅰ genotype in non-small cell lung cancer[J]. J Thorac Oncol,2019,14(6):1021-1031...
[8] NEGRAO M V,LAM V K,REUBEN A,et al. PD-L1 Expression,tumor mutational burden,and cancer gene mutations are stronger predictors of benefit from immune checkpoint blockade than HLA class Ⅰ genotype in non-small cell lung cancer[J]. J Thorac Oncol,2019,14(6):1021-1031. DOI:10. 1016...
1.McGranahan N, Rosenthal R, Hiley C T, et al. Allele-specific HLA loss and immune escape in lung cancer evolution[J]. Cell, 2017, 171(6): 1259-1271. e11. 2.Chowell D, Morris L G T, Grigg C M, et al. Patient HLA cla...
[3] Havel, J. J., D. Chowell and T. A. Chan (2019). "The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy." 19(3): 133-150. [4] McGranahan, N., et al. (2017)."Allele-Specific HLA Loss and Immune Escape in Lung Canc...
2. Han J, Duan J, Bai H, Wang Y, Wan R, Wang X, et al. TCR Repertoire Diversity of Peripheral PD-1(+)CD8(+) T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer....
2008. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. Int J Cancer. 123: 2616.Harao, M., S. Hirata, et al. (2008). "HLA-A2-restricted CTL epitopes of a novel lung cancer-...
题图:站酷海洛 PLUS 投稿:jingshengjie@dxy.cn 参考文献: Jiang T, et al. HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer. Clin Cancer Res. 2023;CCR-23-0604....
最近,河南省肿瘤医院王启鸣团队的吴育锋教授在Immunotherapy (IF 3.028)发表了一篇名为“HLA loss of heterozygosity-mediated discordant responses to immune checkpoint blockade in squamous cell lung cancer with renal metastasis”的Case Report,报道了一例肺鳞癌伴肾转移患者,接受帕博利珠单抗单药治疗,原发灶和肾转...